Skip to content
Screener

Golub Capital GBDC Liabilities

Liabilities at other companies

Cal-Maine Foods logo
Cal-Maine FoodsCALM
$467.04M-9.9%
NewAmsterdam Pharma Company logo
NewAmsterdam Pharma CompanyNAMS
$73.03M+99.5%
SharkNinja logo
SharkNinjaSN
$2.75B
United Therapeutics logo
United TherapeuticsUTHR
$819.8M+11.6%
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
$297.67M-22.3%
Owens Corning logo
Owens CorningOC
$8.92B-3.9%

Other financials

Income statement

See full
Net income-$46.8M-159%
EPS (diluted)-$0.18-160%

Balance sheet

See full
Cash & equivalents$135.2M-45.1%
Total debt$4.7B-2.2%
Total equity$3.7B-7.3%
Total assets$8.5B-4.7%

Cash flow

See full
Operating cash flow$248.8M

Valuation

See full
Market cap$3.42B-13.2%
Enterprise value$7.99B-10.1%
P/E16.7×+6.2×

Returns & leverage

See full
Return on equity5.3%-3.6pp
Debt / equity1.3×+0.1×

Where this comes from

Reported directly by Golub Capital in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The source filing: Golub Capital’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:44 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0001476765-26-000033
Line itemMarch 31, 2026September 30, 2025
Management and income incentive fees payable36,53340,884
Accrued trustee fees6461,039
Accounts payable and other liabilities8,0299,759
Total Liabilities4,781,5774,995,732
Commitments and Contingencies (Note 8)
Net Assets
Preferred stock, par value $0.001 per share, 1,000,000 shares authorized, zero shares issued and outstanding as of March 31, 2026 and September 30, 2025
Common stock, par value $0.001 per share, 500,000,000 shares authorized, 261,147,881 and 266,008,083 shares issued and outstanding as of March 31, 2026 and September 30, 2025, respectively261266

Item 6. Exhibits [181](#i932b8727d4e044838e89e23b24328ce3_244)

FAQ

What is Golub Capital's liabilities?
Golub Capital (GBDC) reported liabilities of $4.78B in Q1 2026.
How has Golub Capital's liabilities changed year-over-year?
Golub Capital's liabilities decreased by 2.5% year-over-year, from $4.91B to $4.78B.
What is the long-term trend for Golub Capital's liabilities?
Over 4 years (2021 to 2025), Golub Capital's liabilities has grown at a 17.9% compound annual growth rate (CAGR), from $2.58B to $5B.
What does liabilities mean?
This represents the total financial obligations and debts owed by the company to external parties. It encompasses all short-term and long-term borrowings, including credit facilities and debt securities issued. For a BDC, this is a key measure of leverage and the capital structure used to finance the investment portfolio.

Ask your AI about Golub Capital's liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude